期刊文献+

不同标准对荧光原位杂交技术在膀胱癌诊断中应用的影响

The Impact of Various Standards in the Diagnosis of Bladder Cancer by Fluorescence in Situ Hybridization
原文传递
导出
摘要 目的:探讨不同标准对荧光原位杂交技术(fluorescence in situ hybridization,FISH)诊断膀胱癌的敏感度和特异性的影响。方法:选择20例健康人为正常组,计算FISH检查正常阈值;选择143例血尿患者为病例组.经FISH检查、尿脱落细胞学检查,比较Urovysion膀胱癌探针试剂盒标准和正常阈值标准诊断膀胱癌的敏感度和特异性。结果:采用Urovysion标准和正常阈值标准对膀胱癌的诊断敏感度分别为73.1%和100%,均较尿脱落细胞学检查明显增高,三者对膀胱癌诊断的特异性分别为90.0%、86%和100%。Urovysion标准与尿脱落细胞学联合检查时对膀胱癌诊断的敏感度明显升高,差异具有统计学意义(P<0.01)。结论:FISH检查较尿脱落细胞学检查诊断膀胱癌的敏感度显著提高,相比Urovysion标准,正常阈值更适合FISH诊断膀胱癌的标准。FISH与尿脱落细胞学联合检查能显著提高膀胱癌的诊断敏感度。 Objective:To find out if the sensitivity and specificity in the diagnosis of bladder cancer by fluorescenee in situ hybridization (FISH) is correlated with various standards. Methods: 20 patients without disease were tested with normal threshold for the FISH as normal group. All 143 patients with hemaluria were investigated by FISH and cytology respectively. We will apply standards adopted by Urovysion bladder cancer kit and the the nor maI threshold standards, and compare the sensitivity and specificity of the diagnosis of bladder cancer by various standards. Results:The sensitivity of diagnosing bladder cancer by Urovysion standard and the normal threshold standard is 73.1% and 100% respectively .and both are higher than that of cytology, the specificity of three diag nosis for bladder cancer is 90.0%, 86%, 100% respectively. The sensitivity of diagnosing bladder cancer would rise when both results were taken consideration meanwhile. The difference has statistically significant ( P 〈0 . 01)Conclusions: The sensitivity of diagnosing bladder cancer by FISH is higher tban by cytology. The normal threshold will be more suit for diagnosing bladder cancer by FISH than Urovysion standard, the sensitivity of diagnosis of bladder cancer will be elevated when both examines were taken.
出处 《临床泌尿外科杂志》 北大核心 2009年第12期889-891,894,共4页 Journal of Clinical Urology
基金 卫生部科研项目(WKJ2007-3-001)
关键词 膀胱癌 荧光原位杂交技术 诊断 bladder cancer fluorescence in situ hybridization diagnose
  • 相关文献

参考文献6

  • 1Fadl-Elmula I. Chromosomal changes in uroepithelial carcinomas[J]. Cell Chromosome, 2005,4 : 1. 被引量:1
  • 2Hoglund M, Sall T, Heim S et al. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinomal [J]. Cancer Res, 2001,61 (22) 8241-8246. 被引量:1
  • 3Skacel M, Fahmy M, Brainard J A ,et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology [J]. J Urol, 2003,169(6) :2101-2105. 被引量:1
  • 4张业贵,毕新刚,韩亚玲,蔡岩,徐昕,吴玉鹏,杨壹羚,马建辉,赵平,贾雪梅,王明荣.多色荧光原位杂交在膀胱尿路上皮癌诊断中的应用[J].癌症,2007,26(2):189-193. 被引量:27
  • 5方炜,金讯波.荧光原位杂交技术在膀胱癌诊断中的应用研究[DB].中国优秀硕士学位论文全文数据库. 被引量:1
  • 6May M, Hakenberg O W, Gunia S, et al. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice[J]. Urology, 2007,70(3) :449-453. 被引量:1

二级参考文献19

  • 1全国肿瘤防治研究办公室.卫生部统计信心中心.中国试点县、市恶性肿瘤的发病与死亡[M].北京:中国医药科技出版社,2002:24—34. 被引量:4
  • 2Prout G R Jr, Barton B A, Griffin P P, et al. Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group [J]. J Urol, 1992,148 (5):1413-1419. 被引量:1
  • 3Raitanen M P, Kaasinen E, Lukkarinen O, et al. Analysis of false-positive BTA STAT test results in patients followe dup for bladder cancer [J]. Urology, 2001,57(4) :680-684. 被引量:1
  • 4Inoue T, Nasu Y, Tsushima T, et al. Chromosomal numerical aberrations of exfoliated cells in the urine detected by fluorescence in situ hybridization: clinical implication for the detection of bladder cancer [J]. Urol Res, 2000,28(1):57-61. 被引量:1
  • 5Sokolova I A, Halling K C, Jenkins R B, et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urotheliai carcinoma in urine [J]. J Mol Diagn, 2000,2(3):116-123. 被引量:1
  • 6Halling K C, King W, Sokolova I A, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma [J]. J Urol, 2000,164(5) :1768-1775. 被引量:1
  • 7Zhang J, Zheng S, Gao Y, et al. A partial allelotyping of urothelial carcinoma of bladder in the Chinese [J].Carcinogenesis, 2004,25 (3): 343-347. 被引量:1
  • 8Veeramachaneni R, Nordberg M L, Shi R, et al. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma [J]. Diagn Cytopathol, 2003,28 (6): 301-307. 被引量:1
  • 9Kruger S, Mess F, Bohle A, et al. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder [J]. Int J Oncol, 2003,23 (1): 41-48. 被引量:1
  • 10Mhawech-Fauceglia P, Fischer G, Beck A, et al. Raf1,Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up [J]. Eur J Surg Ongol, 2006,32(4):439-444. 被引量:1

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部